Ocugen Stock Quote OCGN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.7701

Bid

0.765

Ask

0.775

Volume

21,582,681

0.73 Day's Range 0.7999

0.37 52 Week Range 2.105

Market Cap

224.346M

Previous Close

0.7679

Open

0.751

Last Trade

266

0.7701

(formt)

Last Trade Time

Financial Volume

$ 16,564,751

VWAP

0.767502

Average Volume (3m)

3,731,253

Shares Outstanding

291,320,280

Dividend Yield

PE Ratio

-3.56

Earnings Per Share (EPS)

-0.22

Revenue

6.04M

Net Profit

-63.08M

Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal... Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Ortho,prosth,surg Appl,suply

Website

ocugen.com

Headquarters

Wilmington, Delaware, USA

Founded

2020

Ocugen Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker OCGN. The last closing price for Ocugen was $0.77. Over the last year, Ocugen shares have traded in a share price range of $ 0.37 to $ 2.105.

Ocugen currently has 291,320,280 shares outstanding. The market capitalization of Ocugen is $223.70 million. Ocugen has a price to earnings ratio (PE ratio) of -3.56.

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

OCU410 has a very favorable safety and tolerability profileNo serious adverse events related to the study drug have been reported, such as exudation, infectious endophthalmitis, intraocular...

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference

MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...

Form 4 - Statement of changes in beneficial ownership of securities

Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease

MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...

Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0899	-10.4534883721	0.86	0.89	0.7417	5993661	0.80017858	CS
4	-0.1429	-15.6516976999	0.913	1.02	0.7417	4120927	0.8653842	CS
12	-0.2203	-22.2435379645	0.9904	1.13	0.7417	3731253	0.92764169	CS
26	-0.5999	-43.7883211679	1.37	1.979	0.7417	4316795	1.19536368	CS
52	0.3766	95.7052096569	0.3935	2.105	0.37	5802500	1.25993505	CS
156	-5.0099	-86.6764705882	5.78	5.78	0.345	6136393	1.82468854	CS
260	0.3901	102.657894737	0.38	18.77	0.17	16631010	5.36387527	CS

OCGN - Frequently Asked Questions (FAQ)

What is the current Ocugen share price?

The current share price of Ocugen is $ 0.7701

How many Ocugen shares are in issue?

Ocugen has 291,320,280 shares in issue

What is the market cap of Ocugen?

The market capitalisation of Ocugen is USD 223.7M

What is the 1 year trading range for Ocugen share price?

Ocugen has traded in the range of $ 0.37 to $ 2.105 during the past year

What is the PE ratio of Ocugen?

The price to earnings ratio of Ocugen is -3.56

What is the cash to sales ratio of Ocugen?

The cash to sales ratio of Ocugen is 37.2

What is the reporting currency for Ocugen?

Ocugen reports financial results in USD

What is the latest annual turnover for Ocugen?

The latest annual turnover of Ocugen is USD 6.04M

What is the latest annual profit for Ocugen?

The latest annual profit of Ocugen is USD -63.08M

What is the registered address of Ocugen?

The registered address for Ocugen is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801

What is the Ocugen website address?

The website address for Ocugen is ocugen.com

Which industry sector does Ocugen operate in?

Ocugen operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	281.23M

Symbol

Price

Vol.

EDBLEdible Garden AG Inc

$ 0.24

(65.06%)

354.33M

NVDANVIDIA Corporation

$ 134.70

(3.08%)

310.19M

APTOAptose Biosciences Inc

$ 0.28

(64.51%)

306.25M

TNXPTonix Pharmaceuticals Holding Corporation

$ 0.606999

(6.49%)

293.22M

PLTRPalantir Technologies Inc

$ 80.55

(8.54%)

281.23M

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Ocugen Inc (OCGN) Quote

Ocugen Inc (OCGN)

Professional-Grade Tools, for Individual Investors.

Key stats and details

About Ocugen Inc

Ask ADVFN Intelligence (AI)

OCGN Latest News

OCGN - Frequently Asked Questions (FAQ)

Movers

OCGN Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free